Chastain LM - Search Results

1

Utilizing Clinical Pharmacy Specialists to Address Access to Care Barriers in the Veteran Population for the Management of Diabetes.

Edwards KL, Hadley RL, Baby N, Yeary JC, Chastain LM, Brown CD. Edwards KL, et al. Among authors: chastain lm. J Pharm Pract. 2017 Aug;30(4):412-418. doi: 10.1177/0897190016663952. Epub 2016 Aug 27. J Pharm Pract. 2017. PMID: 27568478

2

Assessment of a didactic ambulatory care pharmacy elective on student perceptions and subsequent performance in an ambulatory care advanced pharmacy practice experience.

Irons BK, Edwards KL, Chastain LM, Black RL, Brown CD, Seifert CF. Irons BK, et al. Among authors: chastain lm. Curr Pharm Teach Learn. 2018 Sep;10(9):1211-1218. doi: 10.1016/j.cptl.2018.06.013. Epub 2018 Jun 27. Curr Pharm Teach Learn. 2018. PMID: 30497624

3

A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia.

Chastain LM, Bain AM, Edwards KL, Bedimo R, Busti AJ. Chastain LM, et al. J Clin Lipidol. 2007 Dec;1(6):634-9. doi: 10.1016/j.jacl.2007.10.003. Epub 2007 Oct 18. J Clin Lipidol. 2007. PMID: 21291706

4

Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population.

Alvarez CA, Russell NM, Edwards KL, Greene RS, Chastain LM, Weideman RA, Busti AJ. Alvarez CA, et al. Among authors: chastain lm. J Clin Lipidol. 2008 Dec;2(6):447-52. doi: 10.1016/j.jacl.2008.10.004. Epub 2008 Oct 25. J Clin Lipidol. 2008. PMID: 21291778

5

Ranolazine for the treatment of refractory angina in a veterans population.

Greene RS, Rangel RM, Edwards KL, Chastain LM, Brouse SD, Alvarez CA, Collins LJ, Brilakis ES, Banerjee S. Greene RS, et al. Among authors: chastain lm. Cardiovasc Revasc Med. 2012 Mar-Apr;13(2):141.e1-5. doi: 10.1016/j.carrev.2011.06.001. Cardiovasc Revasc Med. 2012. PMID: 21856249 Free PMC article.

6

Imeglimin: A Potential New Multi-Target Drug for Type 2 Diabetes.

Vuylsteke V, Chastain LM, Maggu GA, Brown C. Vuylsteke V, et al. Among authors: chastain lm. Drugs R D. 2015 Sep;15(3):227-32. doi: 10.1007/s40268-015-0099-3. Drugs R D. 2015. PMID: 26254210 Free PMC article. Review.

7

Pharmacological management of obesity in patients with type 2 diabetes.

Black RL, Higbea AM, Duval C, Chastain LM. Black RL, et al. Among authors: chastain lm. Expert Rev Endocrinol Metab. 2016 Sep;11(5):415-423. doi: 10.1080/17446651.2016.1220300. Epub 2016 Aug 13. Expert Rev Endocrinol Metab. 2016. PMID: 30058912

8

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide.

Minze MG, Chastain LM. Minze MG, et al. Among authors: chastain lm. Ther Clin Risk Manag. 2016 Mar 29;12:471-8. doi: 10.2147/TCRM.S73579. eCollection 2016. Ther Clin Risk Manag. 2016. PMID: 27099505 Free PMC article. Review.

9

Weight effects of antidiabetic agents.

Higbea AM, Duval C, Chastain LM, Chae J. Higbea AM, et al. Among authors: chastain lm. Expert Rev Endocrinol Metab. 2017 Nov;12(6):441-449. doi: 10.1080/17446651.2017.1395694. Epub 2017 Oct 30. Expert Rev Endocrinol Metab. 2017. PMID: 30063431

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page